Literature DB >> 12655434

Nemaline myopathy and early respiratory failure.

Cyril Schweitzer1, Valérie Danet1, Elisabeth Polu2, François Marchal3, Pierre Monin4.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12655434     DOI： 10.1007/s00431-002-1149-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  Respiratory failure in nemaline myopathy.

Authors:  M Sasaki; M Takeda; K Kobayashi; I Nonaka
Journal:  Pediatr Neurol       Date:  1997-05       Impact factor: 3.372

Review 2.  Pediatric noninvasive nasal ventilation.

Authors:  D J Birnkrant; J F Pope; R M Eiben
Journal:  J Child Neurol       Date:  1997-06       Impact factor: 1.987

3.  Blunted respiratory drive in congenital myopathy.

Authors:  D J Riley; T V Santiago; R P Daniele; B Schall; N H Edelman
Journal:  Am J Med       Date:  1977-09       Impact factor: 4.965

Review 4.  Life without ventilatory chemosensitivity.

Authors:  S A Shea
Journal:  Respir Physiol       Date:  1997-11

5.  Developmental pattern of hypercapnic and hypoxic ventilatory responses from childhood to adulthood.

Authors:  C L Marcus; W B Glomb; D J Basinski; S L Davidson; T G Keens
Journal:  J Appl Physiol (1985)       Date:  1994-01
  5 in total
  1 in total

1.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.